MSB 0.46% $1.09 mesoblast limited

the approvoal process of regenerative medicine. Japan I believe...

  1. 192 Posts.
    lightbulb Created with Sketch. 137
    the approvoal process of regenerative medicine. Japan I believe is the second largest health care market in the world.
    Without them taking a leading role we would still be at the mercy of big pharma. They have been ignoring this technolgy for their own gain.
    Thank you Japan. Thank you for reasonable thinking.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.09
Change
-0.005(0.46%)
Mkt cap ! $1.230B
Open High Low Value Volume
$1.09 $1.09 $1.07 $2.137M 1.986M

Buyers (Bids)

No. Vol. Price($)
28 93497 $1.09
 

Sellers (Offers)

Price($) Vol. No.
$1.09 92650 5
View Market Depth
Last trade - 11.51am 11/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.